At O-Ray, our mission is to develop novel therapies to facilitate improved care and optimally, the cure for serious ear disease. Known for our proprietary drug delivery technologies and pioneering approach to hearing loss, we are grateful recipients of funding both from the private and public sector.

Our objective is to develop therapies from proof of concept to regulatory approval and then license to third parties for sales and marketing.

Our vision is to remain a Research and Development house concentrating on our core competence: rapid development and innovation.

At O-Ray Pharma, our focus is to leverage more than 20 years of experience from our scientific team in extended release delivery systems in a basic and applied research environment. Our early success in securing NIH funding for much of this work is indicative of the level of expertise and the advanced state of O-Ray’s technology.